| ADT | Androgen deprivation therapy |
| AR | Androgen receptor |
| BET | Bromodoman extraterminal enhancer |
| CIS | Carcinoma in situ |
| CRPC | Castrate resistant prostate cancer |
| GEMM | Genetically engineered mouse model |
| HGPIN | High grade PIN |
| IAC | Invasive adenocarcinoma |
| LV | Lentiviral |
| LGPIN | Low grade PIN |
| NEPC | Neuroendocrine Prostate Cancer |
| Pbsn | Probasin |
| PC | Prostate cancer |
| PDX | Patient-derived xenograft |
| PI3K | Phosphoinositol-3 kinase |
| PIN | Prostatic intraepithelial neoplasia |
| Pol | RNA Polymerase |
| TP53 | Tumor suppressor p53 |
| TSG | Tumor suppressor gene |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.